BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 24356598)

  • 1. Prospective study on the incidences of cardiovascular-renal complications in Chinese patients with young-onset type 1 and type 2 diabetes.
    Luk AO; Lau ES; So WY; Ma RC; Kong AP; Ozaki R; Chow FC; Chan JC
    Diabetes Care; 2014; 37(1):149-57. PubMed ID: 24356598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher incidence of cardiovascular-kidney complications in Chinese with youth-onset type 2 diabetes versus youth-onset type 1 diabetes attenuated by control of cardio-metabolic risk factors: A population-based prospective cohort study in Hong Kong.
    Fan Y; Lau ESH; Wu H; Yang A; Chow E; Kong APS; Ma RCW; Chan JCN; Luk AOY
    Diabetes Res Clin Pract; 2023 Aug; 202():110728. PubMed ID: 37217017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of end-stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome.
    Lee YB; Han K; Kim B; Jun JE; Lee SE; Ahn J; Kim G; Jin SM; Kim JH
    Diabetes Metab Res Rev; 2019 Nov; 35(8):e3197. PubMed ID: 31222888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.
    Ma RC; Tam CH; Wang Y; Luk AO; Hu C; Yang X; Lam V; Chan AW; Ho JS; Chow CC; Tong PC; Jia W; Ng MC; So WY; Chan JC
    JAMA; 2010 Aug; 304(8):881-9. PubMed ID: 20736472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal and Cardiovascular Outcomes After Weight Loss From Gastric Bypass Surgery in Type 2 Diabetes: Cardiorenal Risk Reductions Exceed Atherosclerotic Benefits.
    Liakopoulos V; Franzén S; Svensson AM; Sattar N; Miftaraj M; Björck S; Ottosson J; Näslund I; Gudbjörnsdottir S; Eliasson B
    Diabetes Care; 2020 Jun; 43(6):1276-1284. PubMed ID: 32152136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
    Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
    JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA).
    Pease A; Earnest A; Ranasinha S; Nanayakkara N; Liew D; Wischer N; Andrikopoulos S; Zoungas S
    Cardiovasc Diabetol; 2018 Jun; 17(1):77. PubMed ID: 29859534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S; Hansen TW; Rossing P
    Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease.
    Thomas G; Khunti K; Curcin V; Molokhia M; Millett C; Majeed A; Paul S
    Diabetes Obes Metab; 2014 Apr; 16(4):317-25. PubMed ID: 24118783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes.
    Harjutsalo V; Thomas MC; Forsblom C; Groop PH;
    Diabetes Obes Metab; 2018 Dec; 20(12):2759-2767. PubMed ID: 29962015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index.
    Redondo MJ; Foster NC; Libman IM; Mehta SN; Hathway JM; Bethin KE; Nathan BM; Ecker MA; Shah AC; DuBose SN; Tamborlane WV; Hoffman RP; Wong JC; Maahs DM; Beck RW; DiMeglio LA
    Acta Diabetol; 2016 Apr; 53(2):271-7. PubMed ID: 26077171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up.
    Pongrac Barlovic D; Harjutsalo V; Gordin D; Kallio M; Forsblom C; King G; Groop PH;
    Diabetes Care; 2018 Dec; 41(12):2487-2494. PubMed ID: 30257963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study.
    Seven E; Husemoen LL; Sehested TS; Ibsen H; Wachtell K; Linneberg A; Jeppesen JL
    PLoS One; 2015; 10(6):e0128987. PubMed ID: 26035431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
    Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients.
    So WY; Kong AP; Ma RC; Ozaki R; Szeto CC; Chan NN; Ng V; Ho CS; Lam CW; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabetes Care; 2006 Sep; 29(9):2046-52. PubMed ID: 16936151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study.
    Möllsten A; Svensson M; Waernbaum I; Berhan Y; Schön S; Nyström L; Arnqvist HJ; Dahlquist G; ; ;
    Diabetes; 2010 Jul; 59(7):1803-8. PubMed ID: 20424230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
    Villar E; Chang SH; McDonald SP
    Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
    Theilade S; Hansen TW; Goetze JP; Rossing P
    Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Nunez L; Gudbjörnsdóttir S; Eliasson B
    Diabetologia; 2009 Jan; 52(1):65-73. PubMed ID: 18985314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.